Sartorius Stedim Biotech S.A. Stock OTC Markets
Equities
SRTO.Y
US80386Y1010
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.64 USD | +0.68% | -2.87% | -24.75% |
06-03 | SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%) | |
05-16 | Sartorius sinks again towards year low | DP |
Sales 2024 * | 2.94B 3.2B 4.37B | Sales 2025 * | 3.33B 3.62B 4.95B | Capitalization | 18.13B 19.74B 26.99B |
---|---|---|---|---|---|
Net income 2024 * | 335M 365M 499M | Net income 2025 * | 451M 491M 671M | EV / Sales 2024 * | 6.95 x |
Net Debt 2024 * | 2.27B 2.47B 3.38B | Net Debt 2025 * | 2.16B 2.35B 3.21B | EV / Sales 2025 * | 6.1 x |
P/E ratio 2024 * |
52.4
x | P/E ratio 2025 * |
37.7
x | Employees | 10,493 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.58% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech S.A.
1 day | +0.68% | ||
1 week | -2.87% | ||
Current month | -2.87% | ||
1 month | -8.89% | ||
3 months | -25.43% | ||
6 months | +0.54% | ||
Current year | -24.75% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 20.64 | +0.68% | 201 |
24-06-05 | 20.5 | +1.33% | 2,947 |
24-06-03 | 20.23 | -4.80% | 407 |
24-05-30 | 21.25 | +7.05% | 375 |
24-05-29 | 19.85 | -5.92% | 615 |
Delayed Quote OTC Markets, June 06, 2024 at 02:01 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.27% | 180B | |
-0.05% | 108B | |
-1.50% | 68.29B | |
-7.12% | 46.96B | |
+15.24% | 45.64B | |
+7.66% | 42.41B | |
+18.56% | 31.01B | |
+17.09% | 25.51B | |
-6.84% | 23.17B |
- Stock Market
- Equities
- DIM Stock
- SRTO.Y Stock